The COMBINED Study to Integrate Health Behaviour Change for People With a Rotator Cuff Disorder

NCT ID: NCT05829096

Last Updated: 2024-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-03

Study Completion Date

2023-10-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

COMBINED is a pragmatic single-arm feasibility study. The goal of this study is to evaluate the implementation of a physiotherapy-led intervention, The COMBINED approach, to facilitate ongoing refinements, including the strategies for implementation, in readiness for a definitive trial in people with a rotator cuff disorder. The main questions it aims to answer are: 1) What are the key domains of behaviour change influencing the implementation of The COMBINED approach among physiotherapists? 2) Can The COMBINED approach be delivered as intended? 3) Are there any refinements required to the intervention components? 4) What is the patient experience of receiving The COMBINED approach in an NHS setting?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The COMBINED study is looking at how current treatments can be improved for people with shoulder pain, who have been diagnosed with a rotator cuff (RC) disorder. The RC is a group of muscles and tendons which move and stabilise the shoulder joint, and problems with these muscles and tendons can result in pain and difficulty doing everyday tasks.

Current treatments for RC disorders offer only small to moderate benefits and long-term outcomes can be poor. Lifestyle factors, including smoking, being overweight and physical inactivity are associated with the onset and persistence of RC disorders. These factors are linked to modifiable health behaviours that if patients are supported to change, might help improve their shoulder pain. Despite this evidence, physiotherapists do not routinely integrate health behaviour change approaches as part of the management for RC disorders.

The investigators have designed and tested a new complex intervention, The COMBINED approach, that aims to help patients improve their shoulder pain by identifying and assessing the lifestyle factors associated with the onset and persistence of a RC disorder and, where appropriate, the delivery of a brief behaviour change intervention to address these as part of a management plan, supported by a physiotherapist. The investigators have also developed an implementation toolkit to enable and support physiotherapists to effectively deliver this approach in clinical practice. This has been tested and refined in a small usability study, which has led to an optimised version of The COMBINED approach. The investigators would like to find out if this treatment approach can now be delivered within the NHS and to improve this further before testing it in a definitive randomised controlled trial. The overall aim is to provide better care for people with a RC disorder.

This will be a non-randomised feasibility study with qualitative interviews. The study will be conducted in physiotherapy musculoskeletal services across four NHS sites and expected to last 4-6 months. Chartered physiotherapists working at one of the musculoskeletal physiotherapy services, and patients diagnosed with a RC disorder will be eligible to take part.

Physiotherapist participants would be expected to attend a training workshop, deliver the new treatment approach to patients and complete a survey. Patient participants would be asked to attend up to two treatment sessions for their shoulder pain (\~60 mins each) with a qualified physiotherapist. During this treatment session they will be asked some questions about their shoulder pain and other things that could be influencing their shoulder pain, such as if they smoke, their weight and how active they are. Where applicable, the physiotherapist may also measure their height and weight during the consultation. The participants will have an examination of their shoulder. Different treatment options will then be discussed. This will be very similar to what participants would expect in a normal physiotherapy appointment. The treatment sessions will be audio-recorded (with consent), for the purpose of checking what information and treatment was delivered by the physiotherapist in the session. The lead researcher may also request (with consent), to observe one of the treatment sessions. The purpose of this is to identify ways to improve how physiotherapists deliver the new treatment approach.

A selection of patients will be asked to take part in an optional short (up to 20 minutes) telephone interview about their views and experience of the treatment session.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physiotherapy Rotator Cuff Syndrome Rotator Cuff Impingement Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single arm feasibility study
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

N/A, study does not involve pharmaceutical products or medical devices. There is no randomisation involved in this study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention arm

This is a single arm interventional study.

1. A patient-level intervention, which includes:

* An assessment of existing lifestyle factors (smoking status, physical activity levels, and weight) that may be relevant to shoulder pain;
* A brief intervention to support health behaviour change with respect to the target behaviours of smoking cessation, increasing physical activity levels and consuming a healthy diet
* Supporting tools for behaviour change, including an activity workbook for goal-setting and a diary for self-monitoring (attached).

The intervention is to be delivered by physiotherapists, integrated within a routine consultation for people with a RC disorder.
2. A clinician-level implementation toolkit to support the delivery of the clinical intervention, which includes a training package and additional resources e.g. scripts to aid conversations with patients.

Group Type EXPERIMENTAL

The COMBINED approach

Intervention Type OTHER

1. Patient-level intervention:

* Assessment of existing lifestyle factors (smoking status, physical activity levels, and weight) that may be relevant to shoulder pain;
* Brief intervention to support health behaviour change: smoking cessation, increasing physical activity levels and consuming a healthy diet
* Supporting tools for behaviour change, including an activity workbook for goal-setting and a diary for self-monitoring.
2. Clinician-level implementation toolkit:

* Training package including a face-to-face workshop, training manual, recorded role play simulations and an online follow-up training session
* Additional supporting resources; a step-by-step guide to The COMBINED approach, scripts, patient signposting information to support services and a lay summary infographic to explain the links between the health behaviours and RC disorders to patients
* Audit and feedback via observations of consultations to address any 'drift' from the intervention delivery as intended

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The COMBINED approach

1. Patient-level intervention:

* Assessment of existing lifestyle factors (smoking status, physical activity levels, and weight) that may be relevant to shoulder pain;
* Brief intervention to support health behaviour change: smoking cessation, increasing physical activity levels and consuming a healthy diet
* Supporting tools for behaviour change, including an activity workbook for goal-setting and a diary for self-monitoring.
2. Clinician-level implementation toolkit:

* Training package including a face-to-face workshop, training manual, recorded role play simulations and an online follow-up training session
* Additional supporting resources; a step-by-step guide to The COMBINED approach, scripts, patient signposting information to support services and a lay summary infographic to explain the links between the health behaviours and RC disorders to patients
* Audit and feedback via observations of consultations to address any 'drift' from the intervention delivery as intended

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A qualified (HCPC registered) physiotherapist involved in the management of patients with a RC disorder at one of the trial sites;
* Willing to consent to the study procedures, including attending a training workshop, audio-recording of the consultations and audit/feedback on intervention delivery.


* Adult (aged 18 or over);
* Diagnosed with a RC disorder as per the diagnostic criteria in the British Elbow and Shoulder Society guidelines (Kulkarni et al., 2015), which includes pain mid-range on abduction movement, pain on resisted tests and no loss of external rotation, along with screening of the neck and ruling out other conditions (e.g., instability/frozen shoulder). This will be confirmed by the site Principal Investigators (PI), specialist HCPC registered physiotherapists;
* Able to attend at least one face-to-face physiotherapy consultation. Eligibility will be confirmed via physical examination at this session as per the criteria above;
* Able to give full informed consent;
* Willing to consent to the study procedures, including audio-recording of the consultations.

Exclusion Criteria

* Significant trauma;
* Neurological or inflammatory causes of their shoulder pain;
* Any clinical indications of serious pathology.

We will not exclude anyone based upon protected characteristics for example, age and ethnicity. Anyone referred into the physiotherapy department with a RC disorder will be eligible to take part in the study. Measures in place may include support for the consent process, consultation or patient interviews where required, for example, if verbal translation is needed via a hospital interpreter, personal interpreter or telephone translation service.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Manchester Metropolitan University

OTHER

Sponsor Role collaborator

Julie Bury

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Julie Bury

HEE/NIHR Clinical Doctoral Research Fellow

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julie Bury

Role: STUDY_CHAIR

Manchester Metropolitan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals of Leicester

Leicester, Leicestershire, United Kingdom

Site Status

Doncaster and Bassetlaw NHS Foundation Trust

Doncaster, South Yorkshire, United Kingdom

Site Status

Calderdale and Huddersfield NHS Foundation Trsut

Halifax, West Yorkshire, United Kingdom

Site Status

Airedale Foundation Trust

Keighley, West Yorkshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

51451

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.